Application

17786265 · USES OF ANTI-TGF-BETA ANTIBODIES AND CHECKPOINT INHIBITORS FOR THE TREATMENT OF PROLIFERATIVE DISEASES

Filed 2022-06-16 · Abandoned The official file ↗ · Art unit 1641 · Examiner Samantha Lake Hopkins Typical · CPC C07K 16/22 · NOVARTIS AG · Biospark Intellectual Property Law

Office actions

first was Non-final rejection

RCEs

no appeal

To first action

36.6 mo

to disposition 44.0 mo

Statutes raised

102 103 112

1 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.